Search

Chinese
Resource Library / Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug Delivery System for Cannabinoids

poster

Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug Delivery System for Cannabinoids

This study is aimed at developing a Nanoemulsion formulation of a poorly water-soluble and thermally, oxidatively, and photolytically unstable active pharmaceutical ingredient (API) for ophthalmic application, specifically for the reduction of intraocular pressure (IOP) and to provide neuroprotection.

Resources to Consider

Left arrow
Sterile Nanoemulsion Product Development: Challenges and Future Prospects
webinar

Sterile Nanoemulsion Product Development: Challenges and Future...
Nanoemulsion has the potential to overcome several disadvantages in drug formulation. Nano...
Access Resource
Evaluating the feasibility of lyophilization for oral formulation development of monoclonal antibodies (mAbs)​
poster

Evaluating the feasibility of lyophilization for oral formulation...
Objective: To develop a stable lyophilized non-invasive oral formulation of monoclonal ant...
Access Resource
Strategies and Solutions for Early Phase Formulation Development and CTM Manufacturing
webinar

Strategies and Solutions for Early Phase Formulation Development and...
In this webinar, we discuss the strategies to overcome challenges during formulation devel...
Access Resource
Clinical Study of Abuse-Deterrent Formulation to Suppress Release of Hydrocodone
case-study

Clinical Study of Abuse-Deterrent Formulation to Suppress Release of...
A number of the abuse-deterrent formulations in development and available on the market ut...
Access Resource
Nonclinical Vehicle Formulations:HP-β-CD (Hydroxypropyl-Beta-Cyclodextrin) & The Risk of Hemolysis
poster

Nonclinical Vehicle Formulations:HP-β-CD...
Beta-cyclodextrin is a commonly used excipient in nonclinical vehicle formulations. In a r...
Access Resource
Validation of a 384 gene hybridization capture-based pharmacogenomics NGS panel: sensitivity, specificity, accuracy, and reproducibility in calling star alleles for drug metabolism genes
poster

Validation of a 384 gene hybridization capture-based pharmacogenomics...
​Frontage has developed a next-generation sequencing (NGS)-based method to rapidly deter...
Access Resource
Utilizing Ligand Binding Assays (LBA) and Critical Reagents for Drug Development
panel-discussion

Utilizing Ligand Binding Assays (LBA) and Critical Reagents for Drug...
Critical reagents – the key components used in LBA – are central to ensuring the consi...
Access Resource
Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays​
poster

Quantitative Assessment of mRNA Drug Biological Activity by...
Biological activity of mRNA drugs, historically assessed via animal study, is critical to ...
Access Resource
Human Gut Microbiome-Based Contract Research Applications in Toxicology and Microbiome-Based Drug Discovery
webinar

Human Gut Microbiome-Based Contract Research Applications in...
The human gut microbiome contains a complex aggregate of colonic bacterial enzymes mediati...
Access Resource
Characterization of Interchain Cysteine Linked Antibody Drug Conjugates in Mouse Plasma by LC/MS
poster

Characterization of Interchain Cysteine Linked Antibody Drug...
Antibody-drug conjugates (ADCs) have become promising therapy for the treatment of cancers...
Access Resource
Addressing the Increasing Needs of Data Integrity by Implementing the ElectronicSystems in a Paperless Bioanalytical Laboratory
Access Resource
Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using the Simoa HD-X platform
poster

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...
Alzheimer’s disease (AD) is a neurodegenerative disorder which stands as one of the most...
Access Resource
Right arrow